Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is characterised by a rapid rise in viral RNA within the upper respiratory tract, reaching peak levels near symptom onset, ...

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...

An unprecedented study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2 ...

Study conducted by the University of Malaga paves the way for the development of more effective therapies against emerging ...

Virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how our bodies detect and respond to viruses and viral replication. The publication explains ...

Cases of recurrence of clinical symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after completion of treatment with nirmatrelvir–ritonavir have been reported by researchers 1 ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...

Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using AAV vectors.

Reviewed by Carrie D. Johnston, MD, MS, Assistant Professor in the Division of Infectious Diseases at Weill Cornell Medical College in New York City. "Medical Journeys" is a set of clinical resources ...